Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Jin Medical International Ltd. (ZJYL) Financial Statements

Jin Medical International Ltd. (ZJYL) reported trailing twelve-month revenue of $19.7M (down 13.6% year on year) and net income of $1.2M as of 2026-03-31, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$7.0M.

Source: SEC EDGAR filings · figures as of 2026-03-31 · read by EquiReason

ZJYLJin Medical International Ltd.Follow ZJYL — free
Medical Instruments & Supplies · Healthcare
—
Price chart with a free account
Market cap
16.0M
P/E TTM
205.0
Dividend yield
—
52-week
—
Next earnings
—

Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Mar 26.

LineFY2023
Sep 23
FY2024
Sep 24
FY2025
Sep 25
TTM
Mar 26
Trend
Revenue19.823.520.719.7
Gross profit6.89.56.06.0
Research & development1.51.51.6—
Operating income2.93.60.60.4
Pre-tax income3.24.21.61.3
Income tax0.30.80.20.1
Net income2.93.71.21.2
Diluted EPS ($)0.400.400.200.01
Diluted shares (mn)7.37.87.8—

USD millions · SEC XBRL

Jin Medical International Ltd. — questions

What is Jin Medical International Ltd.'s revenue?
$19.7M over the twelve months to 2026-03-31, down 13.6% year on year, from its 10-Q and 10-K filings.
What is Jin Medical International Ltd.'s net income?
$1.2M over the twelve months to 2026-03-31.
What is Jin Medical International Ltd.'s free cash flow?
-$7.0M over the twelve months to 2026-03-31.
What are Jin Medical International Ltd.'s diluted earnings per share?
$0.01 over the twelve months to 2026-03-31.

Every figure on this page comes from Jin Medical International Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.